Online seminar preview: Chinese, UK life science experts to discuss development in post-COVID-19 era

About I·Campus

The Wuxi International Life-Science Innovation Campus (I·Campus) is an open platform for facilitating global innovation co-developed by the Wuxi Municipal Government, Wuxi New District Government, and AstraZeneca. With the goal of "Empowering a Healthy China with Global Wisdom", I·Campus aims to develop a patient-centered, open, and collaborative ecosystem that involves the entire life science innovation process by serving as a hub for 4D industrial elements (Drug, Device, Diagnostic, and Digital) and collaborating with numerous partners, including domestic and international governments, industries, researchers, academics, hospitals, and investors.

About BIA

The BioIndustry Association (BIA) is a trade association for innovative life sciences based in the UK. Its goal is to secure the UK's position as a global hub for innovative research and commercialization, enabling BIA to deliver healthcare solutions that can truly make a difference in people's lives. In 2019, BIA announced a strategic partnership with the Wuxi International Life-Science Innovation Campus (I·Campus).

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines, primarily for the treatment of oncological, cardiovascular, renal, metabolic, and respiratory diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of people around the world. For more information, please visit www.astrazeneca.com.